TORRI MAHROUS: Open Payments
NPI 1720818198 · WEST MONROE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,167 in 64 payments from 20 companies in 2025. Trend: 2023 $0 · 2024 $182 · 2025 $1,167
Food & beverage: $1,167
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 14 | $196 |
| Novo Nordisk Inc | 12 | $193 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $117 |
| Lilly USA, LLC | 5 | $87 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $81 |
| PFIZER INC. | 4 | $78 |
| GlaxoSmithKline, LLC. | 3 | $61 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $50 |
| Viatris Specialty LLC | 2 | $41 |
| AstraZeneca Pharmaceuticals LP | 2 | $39 |
Products named: Kerendia, VRAYLAR, MOUNJARO, Rybelsus, Wegovy, JARDIANCE, CAPLYTA, UBRELVY.
Industry payments across LA — which companies pay providers there.
